Work

PENELOPE: A randomized phase II trial of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab with or without nesuparib, in patients with newly diagnosed advanced or recurrent MMR-proficient endometrial cancer.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps5635

Authors: Se Ik Kim, Hyun-Woong Cho, Chel Hun Choi, Jeong-Yeol Park, Jung Bok Lee, Jae-Weon Kim, Byoung-Gie Kim, John Kim, Jung-Yun Lee

Institutions: Seoul National University, Korea University Guro Hospital, Samsung Medical Center, Asan Medical Center, Yonsei University, Severance Hospital, University of Ulsan, Yonsei University Health System, Yonsei Cancer Hospital, Seoul National University Hospital, Sungkyunkwan University

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410822362

FWCI:

Cites:

Cited by:

Related to: 10